[REVISION HISTORY]
US talc litigation and women's product safety
Updated 1 time since CLSTR started tracking revisions of this situation.
What changed
2026-07-28 09:14 UTC → 2026-07-28 10:23 UTC ·
added
removed
U.S. courts have continued continue to hear large talc lawsuits alleging that asbestos in baby‑powder baby powder caused ovarian cancer and mesothelioma. A California jury awarded $966 million to a mesothelioma patient patient, and companies manufacturers have set aside billions for liability, prompting the removal of talc baby‑powder from U.S. and Canadian markets. At the same time, researchers Researchers have highlighted tumor risks from injectable contraceptives, widening the debate over women’s product safety. Amid these developments, Johnson & Johnson announced a settlement valued estimated at $5.5 billion to resolve about roughly 76,000 U.S. talc‑related claims, with an claims. The deal covers about 99.75 % of outstanding claims and becomes final only if at least 95 % of claimants in federal or state courts accept it. An initial $3 billion payment slated is scheduled for 2027. 2027, with further payments in 2028; the total could rise above $7 billion depending on claimant participation. The agreement company maintains the claims lack merit, while plaintiffs’ counsel described the settlement as fair. The settlement aims to end a decade‑long legal battle over alleged ovarian‑cancer links, though the company maintains the claims lack merit. J&J continues to deny wrongdoing.
Versions
- 2026-07-28 10:23 UTC US talc litigation and women's product safety
- 2026-07-28 09:14 UTC US talc litigation and women's product safety
Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.